{"schema_version":"secwatch.filing_event.v1","accession":"0001096906-23-002456","form_type":"8-K","ticker":"AXIM","cik":"0001514946","company_name":"AXIM BIOTECHNOLOGIES, INC.","filed_at":"2023-12-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.330653+00:00","generated_at":"2026-06-07T06:20:28.854501+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Axim Biotech enters up to $750K convertible note deal with affiliate Medical Marijuana Inc","bullets":["Initial $100,000 note issued Dec 26, 2023; MJNA can purchase up to $750,000 total by June 26, 2025.","Notes bear 5.25% interest, mature Dec 26, 2033; interest payable annually starting Dec 26, 2024.","Conversion price is lesser of $0.01 or 70% of avg two lowest closing prices in prior 10 trading days.","Conversion capped at 4.9% beneficial ownership; notes sold unregistered under Regulation D.","Proceeds for working capital, product development, and clinical trials."],"urls":{"canonical":"https://secwatch.observer/filing/0001096906-23-002456","json":"https://secwatch.observer/filing/0001096906-23-002456.json","markdown":"https://secwatch.observer/filing/0001096906-23-002456.md","text":"https://secwatch.observer/filing/0001096906-23-002456.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514946/000109690623002456/0001096906-23-002456-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514946/000109690623002456/axim-20231226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T06:20:28.854501+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fbecaa875a30ede4b500e18dcd44849de0ac595d","claim":"AXIM BIOTECHNOLOGIES, INC. entered into Convertible Note Purchase Agreement with Medical Marijuana, Inc valued at $750,000 (effective 2023-12-26).","evidence_excerpt":"Effective December 26, 2023, AXIM Biotechnologies, Inc. (the “Company”) entered into a Convertible Note Purchase Agreement (the \"Agreement\") with Medical Marijuana, Inc (“MJNA”), currently an affiliate of the Company and one of its largest shareholders, for the purchase of up to $750,000 face value in convertible notes.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1514946/000109690623002456/0001096906-23-002456-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"Medical Marijuana, Inc"},{"label":"Value","value":"$750,000"},{"label":"Effective","value":"2023-12-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}